Tianjin Lisheng Pharmaceutical Co Ltd
SZSE:002393
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Tianjin Lisheng Pharmaceutical Co Ltd
SZSE:002393
|
CN |
|
T
|
Thales SA
SWB:CSF
|
FR |
|
Kernel Group Holdings Inc
NASDAQ:KRNL
|
US |
|
B
|
BNP Paribas SA
OTC:BNPQF
|
FR |
|
Roche Holding AG
SIX:RO
|
CH |
|
K
|
Korean Drug Co Ltd
KOSDAQ:014570
|
KR |
|
U
|
Unitrade Industries Bhd
KLSE:UNITRAD
|
MY |
|
Vardhman Acrylics Ltd
NSE:VARDHACRLC
|
IN |
|
Enerplus Corp
TSX:ERF
|
CA |
|
Talea Group SpA
MIL:TALEA
|
IT |
|
Euroespes SA
MAD:EEP
|
ES |
|
Esprinet SpA
MIL:PRT
|
IT |
|
Shanghai STEP Electric Corp
SZSE:002527
|
CN |
Bankruptcy Probability
Tianjin Lisheng Pharmaceutical Co Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Tianjin Lisheng Pharmaceutical Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
T
|
Tianjin Lisheng Pharmaceutical Co Ltd
SZSE:002393
|
6B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
871.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
578.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
229B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
296.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
230.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
GSK plc
XETRA:GS71
|
99.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Tianjin Lisheng Pharmaceutical Co Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Tianjin Lisheng Pharmaceutical Co Ltd has total debt of 87.7m CNY. This includes both short-term (81.5m CNY) and long-term (6.2m CNY) debt.
You can find a full breakdown on its Balance Sheet.
